About Kyverna Therapeutics

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
Biotechnology
Location
Location
Suite 550,Emeryville,California,US
Description
Information
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity. synNotch is a trademark of Gilead/Kite.

Kyverna Therapeutics Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about Kyverna Therapeutics

What is Kyverna Therapeutics email format?

The widely used Kyverna Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Kyverna Therapeutics customer service number?

To contact Kyverna Therapeutics customer service number in your country click here to find.


Who is the CEO of Kyverna Therapeutics?

Dominic Borie is the CEO of Kyverna Therapeutics.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more